ArticleMultiple sclerosis and related disorders2020

Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment.

Konrad Rejdak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.